Distinct biomarker roles for HbA1c and glycated albumin in patients with type 2 diabetes on hemodialysis

Journal of Diabetes and its Complications

Volumn 30, Issue 8, 2016, Pages 1494-1499

  Hayashi, Akinori ^a   Takano, Koji ^a   Masaki, Tsuguto ^a   Yoshino, Sonomi ^a   Ogawa, Akifumi ^a   Shichiri, Masayoshi ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Continuous glucose monitoring; Glycated albumin; HbA1c; Hemodialysis; Type 2 diabetes

Indexed keywords

C PEPTIDE; GLUCOSE; GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; GLYCOSYLATED SERUM ALBUMIN; SERUM ALBUMIN;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CONTROLLED STUDY; DIABETIC PATIENT; END STAGE RENAL DISEASE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; AGED; ANALYSIS; BLOOD;

AGED; BIOMARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GLYCATED HEMOGLOBIN A; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS; SERUM ALBUMIN;

EID: 84994360842     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2016.08.015     Document Type: Article

References (44)

1. Bilous, RW, Glycemic control and mortality in diabetic patients undergoing hemodialysis: Much more to learn. American Journal of Kidney Diseases 63 (2014), 10–12.
2. de Jager, DJ, Grootendorst, DC, Jager, KJ, van Dijk, PC, Tomas, LM, Ansell, D,. Dekker, FW, Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA 302 (2009), 1782–1789.
3. Djakoure-Platonoff, C, Radermercker, R, Reach, G, Slama, G, Selam, JI, Accuracy of the continuous glucose monitoring system in inpatient and outpatient conditions. Diabetes & Metabolism 29 (2003), 159–162.
4. Foley, RN, Culleton, BF, Parfrey, PS, Harnett, JD, Kent, GM, Murray, DC, Barre, PE, Cardiac disease in diabetic end-stage renal disease. Diabetologia 40 (1997), 1307–1312.
5. Freedman, BI, Andries, L, Shihabi, ZK, Rocco, MV, Byers, JR, Cardona, CY,. Bleyer, AJ, Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients. Clinical Journal of the American Society of Nephrology 6 (2011), 1635–1643.
6. Genuth, S, Eastman, R, Kahn, R, Klein, R, Lachin, J, Lebovitz, H,. Vinicor, F, Implications of the United Kingdom prospective diabetes study. Diabetes Care 26:Suppl. 1 (2003), S28–S32.
7. Gerstein, HC, Miller, ME, Byington, RP, Goff, DC Jr., Bigger, JT, Buse, JB,. Friedewald, WT, Effects of intensive glucose lowering in type 2 diabetes. The New England Journal of Medicine 358 (2008), 2545–2559.
8. Hill, CJ, Maxwell, AP, Cardwell, CR, Freedman, BI, Tonelli, M, Emoto, M,. Fogarty, DG, Glycated hemoglobin and risk of death in diabetic patients treated with hemodialysis: A meta-analysis. American Journal of Kidney Diseases 63 (2014), 84–94.
9. Inaba, M, Okuno, S, Kumeda, Y, Yamada, S, Imanishi, Y, Tabata, T,. Nishizawa, Y, Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: Effect of anemia and erythropoietin injection. Journal of the American Society of Nephrology 18 (2007), 896–903.
10. Jin, YP, Su, XF, Yin, GP, Xu, XH, Lou, JZ, Chen, JJ,. Ma, JH, Blood glucose fluctuations in hemodialysis patients with end stage diabetic nephropathy. Journal of Diabetes and its Complications 29 (2015), 395–399.
11. Joy, MS, Cefalu, WT, Hogan, SL, Nachman, PH, Long-term glycemic control measurements in diabetic patients receiving hemodialysis. American Journal of Kidney Diseases 39 (2002), 297–307.
12. Kalantar-Zadeh, K, Kopple, JD, Regidor, DL, Jing, J, Shinaberger, CS, Aronovitz, J,. Sharma, K, A1C and survival in maintenance hemodialysis patients. Diabetes Care 30 (2007), 1049–1055.
13. Kashiwagi, A, Kasuga, M, Araki, E, Oka, Y, Hanafusa, T, Ito, H,. Ohashi, H, International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values. Journal of Diabetes Investigation 3 (2012), 39–40.
14. Kikkawa, R, Arimura, T, Haneda, M, Nishio, T, Sawada, K, Yagisawa, M, Shigeta, Y, Current status of type 2 (non-insulin-dependent) diabetic subjects on dialysis therapy in Japan. Diabetologia 36 (1993), 1105–1108.
15. Kobayashi, H, Abe, M, Yoshida, Y, Suzuki, H, Maruyama, N, Okada, K, Glycated albumin versus glycated hemoglobin as a glycemic indicator in diabetic patients on peritoneal dialysis. International Journal of Molecular Sciences, 17, 2016.
16. Koch, M, Kutkuhn, B, Grabensee, B, Ritz, E, Apolipoprotein A, fibrinogen, age, and history of stroke are predictors of death in dialysed diabetic patients: a prospective study in 412 subjects. Nephrology Dialysis Transplantation 12 (1997), 2603–2611.
17. Koch, M, Thomas, B, Tschope, W, Ritz, E, Survival and predictors of death in dialysed diabetic patients. Diabetologia 36 (1993), 1113–1117.
18. Koga, M, Murai, J, Morita, S, Saito, H, Kasayama, S, Comparison of annual variability in HbA1c and glycated albumin in patients with type 1 vs. type 2 diabetes mellitus. Journal of Diabetes and its Complications 27 (2013), 211–213.
19. Kovesdy, CP, Park, JC, Kalantar-Zadeh, K, Glycemic control and burnt-out diabetes in ESRD. Seminars in Dialysis 23 (2010), 148–156.
20. Kovesdy, CP, Sharma, K, Kalantar-Zadeh, K, Glycemic control in diabetic CKD patients: Where do we stand?. American Journal of Kidney Diseases 52 (2008), 766–777.
21. Leinung, M, Thompson, S, Nardacci, E, Benefits of continuous glucose monitor use in clinical practice. Endocrine Practice 16 (2010), 371–375.
22. Lo, C, Lui, M, Ranasinha, S, Teede, HJ, Kerr, PG, Polkinghorne, KR,. Zoungas, S, Defining the relationship between average glucose and HbA1c in patients with type 2 diabetes and chronic kidney disease. Diabetes Research and Clinical Practice 104 (2014), 84–91.
23. Medina, RA, Pugh, JA, Monterrosa, A, Cornell, J, Minority advantage in diabetic end-stage renal disease survival on hemodialysis: Due to different proportions of diabetic type?. American Journal of Kidney Diseases 28 (1996), 226–234.
24. Mehrotra, R, Kalantar-Zadeh, K, Adler, S, Assessment of glycemic control in dialysis patients with diabetes: Glycosylated hemoglobin or glycated albumin?. Clinical Journal of the American Society of Nephrology 6 (2011), 1520–1522.
25. Morioka, T, Emoto, M, Tabata, T, Shoji, T, Tahara, H, Kishimoto, H,. Nishizawa, Y, Glycemic control is a predictor of survival for diabetic patients on hemodialysis. Diabetes Care 24 (2001), 909–913.
26. Ogawa, A, Hayashi, A, Kishihara, E, Yoshino, S, Takeuchi, A, Shichiri, M, New indices for predicting glycaemic variability. PloS One, 7, 2012, e46517.
27. Okada, T, Nakao, T, Matsumoto, H, Shino, T, Nagaoka, Y, Tomaru, R, Wada, T, Association between markers of glycemic control, cardiovascular complications and survival in type 2 diabetic patients with end-stage renal disease. Internal Medicine 46 (2007), 807–814.
28. Park, J, Lertdumrongluk, P, Molnar, MZ, Kovesdy, CP, Kalantar-Zadeh, K, Glycemic control in diabetic dialysis patients and the burnt-out diabetes phenomenon. Current Diabetes Reports 12 (2012), 432–439.
29. Patel, A, MacMahon, S, Chalmers, J, Neal, B, Billot, L, Woodward, M,. Travert, F, Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. The New England Journal of Medicine 358 (2008), 2560–2572.
30. Peacock, TP, Shihabi, ZK, Bleyer, AJ, Dolbare, EL, Byers, JR, Knovich, MA,. Freedman, BI, Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis. Kidney International 73 (2008), 1062–1068.
31. Rhee, CM, Leung, AM, Kovesdy, CP, Lynch, KE, Brent, GA, Kalantar-Zadeh, K, Updates on the management of diabetes in dialysis patients. Seminars in Dialysis 27 (2014), 135–145.
32. Rodbard, D, New and improved methods to characterize glycemic variability using continuous glucose monitoring. Diabetes Technology & Therapeutics 11 (2009), 551–565.
33. Schlichtkrull, J, Munck, O, Jersild, M, The M-valve, an index of blood-sugar control in diabetics. Acta Medica Scandinavia 177 (1965), 95–102.
34. Selvin, E, Rawlings, AM, Grams, M, Klein, R, Sharrett, AR, Steffes, M, Coresh, J, Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study. The Lancet Diabetes & Endocrinology 2 (2014), 279–288.
35. Service, FJ, Nelson, RL, Characteristics of glycemic stability. Diabetes Care 3 (1980), 58–62.
36. Service, FJ, Molnar, GD, Rosevear, JW, Ackerman, E, Gatewood, LC, Taylor, WF, Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 19 (1970), 644–655.
37. Shima, K, Komatsu, M, Kawahara, K, Minaguchi, J, Kawashima, S, Stringent glycaemic control prolongs survival in diabetic patients with end-stage renal disease on haemodialysis. Nephrology (Carlton, Vic.) 15 (2010), 632–638.
38. Sunagawa, H, Iseki, K, Nishime, K, Uehara, H, Toma, S, Kinjo, K, Fukiyama, K, Epidemiologic analysis of diabetic patients on chronic dialysis. Nephron 74 (1996), 361–366.
39. Suzuki, Y, Arakawa, M, The treatment of the uraemic diabetic. Are we doing enough? A view from Japan. Fumitake Gejyo and Collaborate Study Group. Nephrology Dialysis Transplantation 10:Suppl. 7 (1995), 47–55.
40. Tschope, W, Koch, M, Thomas, B, Ritz, E, Serum lipids predict cardiac death in diabetic patients on maintenance hemodialysis. Results of a prospective study. The German Study Group Diabetes and Uremia. Nephron 64 (1993), 354–358.
41. Vos, FE, Schollum, JB, Coulter, CV, Manning, PJ, Duffull, SB, Walker, RJ, Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring. Nephrology (Carlton, Vic.) 17 (2012), 182–188.
42. Wojcicki, JM, “J”-index. A new proposition of the assessment of current glucose control in diabetic patients. Hormone and Metabolic Research 27 (1995), 41–42.
43. Wu, MS, Yu, CC, Yang, CW, Wu, CH, Haung, JY, Hong, JJ,. Leu, ML, Poor pre-dialysis glycaemic control is a predictor of mortality in type II diabetic patients on maintenance haemodialysis. Nephrology Dialysis Transplantation 12 (1997), 2105–2110.
44. Yoshiuchi, K, Matsuhisa, M, Katakami, N, Nakatani, Y, Sakamoto, K, Matsuoka, T,. Hori, M, Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes. Endocrine Journal 55 (2008), 503–507.